{"id":"NCT00453349","sponsor":"Bayer","briefTitle":"A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease","officialTitle":"A Prospective, Randomized, Double Dummy, Double Blind, Multi-center Multinational Trial Comparing the Efficacy and Safety of Moxifloxacin 400 mg PO QD 24 Hours for 14 Days to That of Levofloxacin 500 mg PO QD 24 Hours Plus Metronidazole 500 mg BID for 14 Days in Subjects With an Uncomplicated Pelvic Inflammatory Disease (PID). Moxifloxacin, Metronidazole, and Levofloxacin in Asia (MONALISA Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-01","primaryCompletion":"2008-05","completion":"2008-05","firstPosted":"2007-03-28","resultsPosted":"2009-11-30","lastUpdate":"2014-09-08"},"enrollment":460,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pelvic Inflammatory Disease"],"interventions":[{"type":"DRUG","name":"Moxifloxacin (Avelox, BAY12-8039)","otherNames":[]},{"type":"DRUG","name":"Levofloxacin & Metronidazole","otherNames":[]}],"arms":[{"label":"Moxifloxacin","type":"EXPERIMENTAL"},{"label":"Levofloxacin plus Metronidazole","type":"ACTIVE_COMPARATOR"}],"summary":"To assess the efficacy and safety of oral moxifloxacin compared to oral levofloxacin plus oral metronidazole in uncomplicated pelvic inflammatory disease (PID)","primaryOutcome":{"measure":"Clinical Response 7 to 14 Days After Completion of Study Drug Therapy in Per Protocol (PP) Population","timeFrame":"7 - 14 days after completion of study drug therapy","effectByArm":[{"arm":"Moxifloxacin","deltaMin":152,"sd":null},{"arm":"Levofloxacin Plus Metronidazole","deltaMin":155,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":13,"countries":["China","Indonesia","Pakistan","Philippines","South Korea","Taiwan","Thailand"]},"refs":{"pmids":["20716255"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":225},"commonTop":["Nausea","Dizziness","Abdominal pain upper","Vomiting","Insomnia"]}}